These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2071888)

  • 1. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes.
    Hindmarch I; Fuchs HH; Erzigkeit H
    Int Clin Psychopharmacol; 1991; 6(1):31-43. PubMed ID: 2071888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients.
    Kemény V; Molnár S; Andrejkovics M; Makai A; Csiba L
    J Clin Pharmacol; 2005 Sep; 45(9):1048-54. PubMed ID: 16100299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
    Balestreri R; Fontana L; Astengo F
    J Am Geriatr Soc; 1987 May; 35(5):425-30. PubMed ID: 3553281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and lack of efficacy of vinpocetine in Alzheimer's disease.
    Thal LJ; Salmon DP; Lasker B; Bower D; Klauber MR
    J Am Geriatr Soc; 1989 Jun; 37(6):515-20. PubMed ID: 2715559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
    Zhang W; Huang Y; Li Y; Tan L; Nao J; Hu H; Zhang J; Li C; Kong Y; Song Y
    Clin Drug Investig; 2016 Sep; 36(9):697-704. PubMed ID: 27283947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinpocetine, cognition, and epilepsy.
    Meador KJ; Leeman-Markowski B; Medina AE; Illamola SM; Seliger J; Novak G; Lin C; Ivanisevic M; Razavi B; Marino S; Boyd A; Loring DW
    Epilepsy Behav; 2021 Jun; 119():107988. PubMed ID: 33957389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L
    Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
    Zhang P; Cao Y; Chen S; Shao L
    Pharmacology; 2021; 106(1-2):37-44. PubMed ID: 32294652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic brain syndrome treated with oxiracetam. A double-blind randomized controlled trial.
    Hjorther A; Browne E; Jakobsen K; Viskum P; Gyntelberg F
    Acta Neurol Scand; 1987 Apr; 75(4):271-6. PubMed ID: 3296624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.
    Naber D; Greenspan A; Schreiner A
    Psychopharmacology (Berl); 2007 May; 191(4):1027-9. PubMed ID: 17333131
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcranial Doppler assessment of cerebral vasomotor reactivity in evaluating the effects of vinpocetine in cerebral small vessel disease: a pilot study.
    Jovanović ZB; Pavlović AM; Pekmezović T; Mijajlović M; Covicković NS
    Ideggyogy Sz; 2013 Jul; 66(7-8):263-8. PubMed ID: 23971358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of vinpocetine therapy in acute ischaemic stroke.
    Bereczki D; Fekete I
    Eur J Clin Pharmacol; 1999 Jul; 55(5):349-52. PubMed ID: 10456483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.
    Grandt R; Braun W; Schulz HU; Lührmann B; Frercks HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1451-4. PubMed ID: 2515864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
    J Neurol Sci; 2005 Mar; 229-230():275-84. PubMed ID: 15760651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.